Robert MD's Company Details
Woburn, Massachusetts, US • 39 Employees
BioTech/Drugs
We're a biotech company dedicated to advancing antibody therapeutics for severe diseases. Focusing on immuno-oncology and ophthalmology, we leverage our proprietary DiversImmune® and MultiMab platforms to develop next-gen antibodies. Collaborating with global pharmaceutical and research partners, we're building a robust pipeline of innovative treatments.
For more information, please visit https://abpro.com/
High Speed Monoclonal Antibody Generation
Antibodies that Cover a Broader Epitope Spread
Assay Development
Anti-Idiotypic Antibodies
Functional GPCR Antibodies
Antibodies to High Homology Targets
Preclinical Animal Services
Lentivirus Expression
Immunology
Angiogenesis
Immuno-Oncology
Ophthalmology
Cancer
Therapeutics
Antibody
Bi-Specific Antibody
B2B
BioTech/Drugs
Commercial Physical Research
Biotechnology